Lineage Cell Therapeutics

Call Directions Website Contact the business

Lineage Cell Therapeutics Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

Join us on September 29 for the Spinal Cord Injury Patient-Focused Drug Development Meeting, a free, virtual event! The ...
09/23/2026

Join us on September 29 for the Spinal Cord Injury Patient-Focused Drug Development Meeting, a free, virtual event!

The SCI PFDD meeting provides a mechanism to identify meaningful treatment outcomes and document the SCI lived experience, with the FDA hearing directly from people living with SCI and care partners. Conducting comparable concept elicitation research independently could cost $500,000 to $1 million and take one to two years.

Attendees can contribute through live polling and comments, and what they share will become part of an official report that the FDA and treatment developers can use to help shape future treatments.

Lineage Cell Therapeutics is proud to support this event.

Register today and join the discussion: https://www.scipfdd.org/register

Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine Unite 2 Fight Paralysis American Spinal Injury Association - ASIA Craig H. Neilsen Foundation Paralyzed Veterans of America North American Spinal Cord Injury Consortium United Spinal Association Wings for Life

Every experience with spinal cord injury (SCI) is different. Hearing from across the community gives the FDA, researcher...
09/16/2026

Every experience with spinal cord injury (SCI) is different. Hearing from across the community gives the FDA, researchers, and treatment developers a fuller picture of what people living with SCI need from current and future treatments.

Lineage is proud to support the SCI PFDD Meeting, an opportunity to put the priorities and unmet needs of people living with SCI at the center of treatment development and evaluation.

Join the free, virtual SCI PFDD Meeting on September 29 from 10:00 AM–3:00 PM ET to listen, participate in live polling, and add your perspective to the discussion. Anyone with a personal or professional connection to spinal
cord injury is welcome.

Register today and join the conversation: https://www.scipfdd.org/register

Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine Unite 2 Fight Paralysis American Spinal Injury Association - ASIA Craig H. Neilsen Foundation Paralyzed Veterans of America North American Spinal Cord Injury Consortium United Spinal Association Wings for Life

Lineage Cell Therapeutics is proud to support the upcoming Spinal Cord Injury Patient-Focused Drug Development (PFDD) Me...
09/09/2026

Lineage Cell Therapeutics is proud to support the upcoming Spinal Cord Injury Patient-Focused Drug Development (PFDD) Meeting on September 29!

This free, virtual meeting gives individuals with SCI an opportunity to share their experiences directly with the FDA and treatment developers. Whether you live with SCI, support someone who does, work in SCI care or research, or advocate for the community, you are welcome to attend. The more people who show up, the stronger the message.

Register today: https://www.scipfdd.org/register

Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine Unite 2 Fight Paralysis American Spinal Injury Association - ASIA Craig H. Neilsen Foundation Paralyzed Veterans of America North American Spinal Cord Injury Consortium United Spinal Association Wings for Life

On World SCI Day, all of us at Lineage Cell Therapeutics want to recognize the decade of collective global effort to rai...
09/05/2026

On World SCI Day, all of us at Lineage Cell Therapeutics want to recognize the decade of collective global effort to raise awareness, strengthen prevention, and advance meaningful action for people living with spinal cord injury.

Learn more about World SCI Day: https://www.iscos.org.uk/page/SciDay



The International Spinal Cord Society - ISCoS

08/06/2026

Lineage Cell Therapeutics reported second quarter 2026 financial results and will host a conference call at 4:30 pm ET / 1:30 pm PT today to provide a business update.

Learn more: https://bit.ly/4xtq2io

Lineage Cell Therapeutics thanks Drug Discovery World and editor Diana Turner for featuring CEO Brian Culley in the Summ...
07/22/2026

Lineage Cell Therapeutics thanks Drug Discovery World and editor Diana Turner for featuring CEO Brian Culley in the Summer 2026 issue.

Brian discusses the potential of cell replacement therapies in ophthalmology, including Lineage’s recently launched and wholly owned COR1 preclinical program for corneal endothelial disease, and its AlloSCOPE™ manufacturing platform. https://bit.ly/4pwHPT7

Lineage Cell Therapeutics wishes to thank Eyecelerator and distinguished moderators Allen Ho, MD, FACS, and SriniVas Sad...
07/21/2026

Lineage Cell Therapeutics wishes to thank Eyecelerator and distinguished moderators Allen Ho, MD, FACS, and SriniVas Sadda, MD, FARVO, for including the OpRegen® cell therapy program in the panel “Is Vision Improvement on the Horizon for Regenerative Medicine?” at Eyecelerator @ ARVO 2026.

Watch the full panel on YouTube: https://www.youtube.com/watch?v=wXamuo9kZjA

Genentech |

Lineage Cell Therapeutics will discuss progress with its COR1 preclinical program for corneal endothelial disease during...
07/13/2026

Lineage Cell Therapeutics will discuss progress with its COR1 preclinical program for corneal endothelial disease during a conference call today at 4:30 p.m. ET / 1:30 p.m. PT.

For more: https://bit.ly/4vv3qwC

Address

2173 Salk Avenue, Suite 200
Carlsbad, CA
92008

Telephone

+15108714188

Website

Alerts

Be the first to know and let us send you an email when Lineage Cell Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Lineage Cell Therapeutics:

Shortcuts

Share

Category